Related Experiment Video

Updated: Jun 6, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

[Macrosomic infants: clinical problems at birth and afterward]

R Lucchini1, G Barba, S Giampietro

  • 1Dipartimento di Pediatria, Sapienza-Università di Roma.

Minerva Pediatrica
|November 25, 2010
PubMed

Insights

Macrosomic infants, or those with high birth weight, face greater risks of immediate health issues and later-life metabolic syndrome. This risk follows a "U" shaped curve, not a linear one, concerning birth weight.

Area of Science:

  • Neonatal health
  • Metabolic syndrome research
  • Pediatric health outcomes

Background:

  • Macrosomic infants (birth weight >4000 g) experience elevated risks of shoulder dystocia, hypoglycemia, and respiratory distress.
  • Higher neonatal birth weight is directly correlated with increased risks of immediate infant complications.

Purpose of the Study:

  • To investigate the relationship between birth weight and the risk of developing metabolic syndrome later in life.
  • To elucidate the non-linear nature of the association between high birth weight and metabolic syndrome development.

Main Methods:

  • Analysis of birth weight data in relation to infant health outcomes.
  • Longitudinal study assessing the correlation between neonatal birth weight and the incidence of metabolic syndrome in later life.

Main Results:

  • A direct relationship exists between higher birth weight and increased neonatal risks.
  • The association between birth weight and later-life metabolic syndrome is not linear but exhibits a "U" shaped pattern.

Conclusions:

  • Neonatal birth weight is a critical factor influencing both immediate infant health and long-term metabolic health.
  • The "U" shaped relationship highlights that both low and high birth weights may confer increased risk for metabolic syndrome.

More Related Videos

A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect05:04

A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect

Published on: September 22, 2023

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...